Melanoma Antigen Family B, 3 (MAGEB3) (N-Term) Peptide
MAGEB3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all MAGEB3 products
- MAGEB3 (Melanoma Antigen Family B, 3 (MAGEB3))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MAGEB3 antibody (Catalog #: ARP56339_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MAGEB3 (Melanoma Antigen Family B, 3 (MAGEB3))
- Synonyms
- CT3.5 Peptide, Smage3 Peptide, Mage-b3 Peptide, Mage-ps1 Peptide, Mage-rs3 Peptide, RGD1562343 Peptide, MAGEB3 Peptide, MAGE family member B3 Peptide, melanoma antigen, family B, 3 Peptide, melanoma-associated antigen B3 Peptide, MAGE family member B5 Peptide, MAGEB3 Peptide, Mageb3 Peptide, LOC509870 Peptide, MAGEB5 Peptide
- Background
-
This gene is a MAGE-B subfamily member of the MAGE gene family. MAGE family member proteins direct the expression of tumor antigens recognized on a human melanoma by autologous cytolytic T lymphocytes. There are two known clusters of MAGE genes on chromos
Alias Symbols: CT3.5
Protein Size: 346 - Molecular Weight
- 39 kDa
- Gene ID
- 4114
- NCBI Accession
- NM_002365, NP_002356
- UniProt
- O15480
-
You are here:
